Illumina has appointed Charles Dadswell as its new senior vice president and general counsel. Dadswell replaces Christian Cabou, who has retired, and is responsible for all of the company's legal and IP matters.
Dadswell joins Illumina from bioMerieux, where he was vice president and general counsel for North and Latin America and corporate director of global intellectual property at bioMerieux.
Aushon Biosystems has appointed Susan Vogt as its new CEO. Before joining the Billerica, Mass.-based array firm, she held executive posts at SeraCare Life Sciences and at Millipore. Vogt takes over from Martin Verhoef, who held the CEO post for six months.
IntegenX has named Robert Schueren as its new CEO.
Schueren most recently served as vice president and general manager of genomics for Agilent Technologies. Prior to joining Agilent in 2010, he was the global head of clinical biomarkers and operations and the deputy global head of molecular medicine labs at Genentech.
Applied BioCode has appointed Michael Aye as vice president of molecular products.
Aye worked previously at Focus Diagnostics and Beckman Coulter. Before that, he spent 10 years in academia focused on research in molecular genetics and microbiology.